Younger Heart Attack Patients More Likely to Have Low “Good” Cholesterol vs. Elevated “Bad” Cholesterol


09 Mar 2017 --- Men under 45 years old and women under 50 years old who suffer a heart attack are far more likely to have abnormally low good cholesterol than elevated bad cholesterol, according to research scheduled for presentation at the American College of Cardiology’s 66th Annual Scientific Session.

Elevated LDL-C, known as “bad” cholesterol, is considered a risk factor for a heart attack or stroke because it suggests that arteries are clogged with deposits known as plaque. 

HDL-C, known as “good” cholesterol, acts like a scavenger, scouring the blood to get rid of excess fat and bad cholesterol. Healthy levels of HDL-C (above 40 in men, above 50 in women) may protect against heart attacks and strokes, partly due to HDL-C’s role in clearing bad cholesterol from the arteries, reducing inflammation and preventing blood clots, whereas low levels of HDL-C have been shown to increase risk.

“In this study of younger heart attack patients, low HDL-C was the most common abnormality, seen in approximately 90 percent of the men and 75 percent of the women,” said Bradley Collins, a fourth-year student at Harvard Medical School and lead author of the study. “This finding suggests that low HDL-C should be considered a marker of increased heart attack risk in younger patients particularly.”

Collins spoke with NutritionInsight: “Many consumers understand that there is a “good” (HDL-C) and “bad” (LDL-C) cholesterol, but do not quite understand how to increase the good and decrease the bad.”  
“Lowering fat intake (especially saturated fats) and lowering cholesterol intake are both beneficial to improving your LDL-C.  Foods high in trans-fats such as hydrogenated oils should be avoided, as they can increase bad cholesterol (LDL-C) and lower the good cholesterol (HDL-C),” he explains. “Instead, individuals should focus on consuming healthier fats such as nuts, avocado, and olive oil which are high in monounsaturated and polyunsaturated fats, which can increase HDL cholesterol, and have other beneficial properties.”   
He also said: “There are a variety of risk calculators that physicians use to stratify cardiovascular risk.  A particularly useful one is the ACC/AHA 2013 pooled cohort equation which allows one to calculate the risk of future ASCVD (atherosclerotic cardiovascular disease) and subsequently determine if they are candidates for statin therapy.  However, many of these calculations require knowledge of very specific lipid values (and may project artificially lower risk for younger patients, as they rely heavily on age).”  
“Because individuals with low HDL-C have a higher risk, they should address all modifiable risk factors, not just HDL-C,” he notes. “However, when it comes to HDL-C, the good news is that HDL-C can be a modifiable risk factor, meaning that people can take action to increase HDL-C.”

“Instituting lifestyle changes such as smoking cessation, maintaining a healthy weight, finding ways to be more physically active, and eating more fruit and vegetables while avoiding unhealthy fats, such as trans-fats, can improve “good” HDL cholesterol. In addition to raising HDL-C, these methods can also help to diminish other cardiovascular risk factors (while lowering blood pressure and improving blood sugar levels),” Collins explained.   

Through a review of billing data and medical records at two large medical centers, Collins and his co-authors identified 813 men under 45 years old and women under 50 years old who had been treated for a heart attack over the past 16 years. The patients’ average age was 48; 38 percent were women.

The finding that these younger heart attack patients were more likely to have low HDL-C than to have elevated LDL-C suggests that different measures may need to be used to accurately identify heart attack risk in this age group, Collins said.

Furthermore, traditional tools for calculating heart attack risk may underestimate risk in younger patients by putting too much emphasis on patient age, he said.

The average age for a heart attack in the United States is 65 for men and 70 for women.

In 2013, an estimated 750,000 Americans had a heart attack. Of these, about 116,000 died. 

Although both the annual number of heart attacks and the annual number of deaths from heart attacks have been declining in recent years, some data suggest these reductions may not be happening in younger people. Recent studies have shown that while hospitalization rates for heart attacks declined more than 20 percent over a 10-year period among patients with an average age of 75, there was no such decline among patients under 55.

Researchers said current data suggest that while treatments primarily aimed at increasing HDL-C have not been shown to decrease cardiovascular events, low HDL-C should be viewed as a risk marker for heart attacks, regardless of LDL-C levels. Thus, low HDL-C should prompt the initiation of preventive measures, such as lifestyle changes, better glucose and blood pressure control, and medications to lower LDL-C. Combining all these measures together can lead to significant improvement in overall cardiovascular health, Collins said.

HDL-C is often a “modifiable” risk factor for heart disease—that means people can take action to increase HDL-C by giving up smoking, maintaining a healthy weight, finding ways to be more physically active, and eating more fruit and vegetables while avoiding unhealthy fats, such as trans fats.

“For many people, heart attacks can be prevented by following a healthy lifestyle. When we identify individuals who have a higher risk, however, we can achieve the greatest risk reduction by combining a healthy lifestyle with medications,” Collins said.

A limitation of the current study is that it is based on data from a fairly small number of patients who were treated at just two medical centers.

The researchers are exploring several possible studies to follow up on these findings, Collins said.

“We are examining whether low HDL-C also predicts risk for repeat heart attacks in younger patients and whether there are genetic risk factors in this population,” he said. “We also want to look at prescribing patterns for statins in younger patients who are at increased risk for heart disease. Ultimately, we would like to develop new tools for calculating heart attack risk that are more applicable to younger people.”

Collins will also present other data from the same study showing that, compared with men, women who have a heart attack before age 50 have a significantly higher rate of death from any cause. These younger women are also more likely to have what is known as a Type 2 heart attack, which occurs when a problem other than a blocked artery causes the heart to need more oxygen than it can get.

“A Type 2 heart attack may occur in patients who have other very complicated medical conditions, including terminal cancer, internal bleeding or a severe bacterial infection,” Collins said. “These heart attacks are often overlooked, given the severity of the patient’s main diagnosis.”

The next phase of this research will examine how many patients died of heart disease as opposed to other conditions.

Collins will present the studies, “Lipid Abnormalities in Young Patients with Myocardial Infarction” and “Women Who Experience Myocardial Infarction at a Young Age Have Worse Survival Compared With Men” on Friday, March 17, at 1:30 p.m. ET at Poster Hall C at the American College of Cardiology’s 66th Annual Scientific Session in Washington. The meeting runs March 17-19.

by Hannah Gardiner


Lonza: Positive start to 2018, driven by expanding healthcare businesses

04 May 2018 Lonza has reported a “positive” ...


Nexira enters strategic partnership for nutritionals, not giving up its acquisition plans

02 May 2018 Nexira, a global leader in natural and organic ...


DSM benefits from high vitamin prices in Q1, raises outlook

12 Apr 2018 DSM has pre-announced better-than-expected ...


GSK to take full ownership of Novartis stake in Consumer Healthcare Business for US$13bn

27 Mar 2018 GlaxoSmithKline (GSK) has reached an agreement ...


Ancient becomes modern: US$103 million investment for bone broth innovator

12 Mar 2018 Ancient Nutrition, a bone broth protein and ...